1. (3) F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D. A. Berk, V. O. Torchilin, and R. K. Jain : “Vascular Permeability in a Human Tumor Xenograft: Molecular Size Dependence and Cutoff Size”, Cancer Res., Vol. 55, pp. 3752-3756 (1995)
2. (4) H. Maeda, G. Y. Bharate, and J. Daruwalla : “Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect”, Eur. J. Pharm. Biopharm., Vol. 71, pp. 409-419 (2009)
3. (6) S. Nishijima, F. Mishima, Y. Tabata, H. Iseki, Y. Muragaki, A. Sasaki, and N. Saho : “Research and Development of Magnetic Drug Delivery System Using Bulk High Temperature Superconducting Magnet”, IEEE Trans. Appl. Supercond., Vol. 19, No. 3, pp. 2257-2260 (2009)
4. (7) T. Fuchigami, R. Kawamura, Y. Kitamoto, M. Nakagawa, and Y. Namiki : “Ferromagnetic FePt-Nanoparticles/Polycation Hybrid Capsules Designed for a Magnetically Guided Drug Delivery System”, Langmuir, Vol. 27, No. 6, pp. 2923-2928 (2011)
5. (8) T. Fuchigami, R. Kawamura, Y. Kitamoto, M. Nakagawa, and Y. Namiki : “A magnetically guided anti-cancer drug delivery system using porous FePt capsules”, Biomaterials, Vol. 33, pp. 1682-1687 (2012)